179 related articles for article (PubMed ID: 12924612)
1. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
Klingel R; Fassbender T; Fassbender C; Göhlen B
Ther Apher Dial; 2003 Jun; 7(3):350-8. PubMed ID: 12924612
[TBL] [Abstract][Full Text] [Related]
2. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
Klingel R; Mausfeld P; Fassbender C; Goehlen B
Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
[TBL] [Abstract][Full Text] [Related]
3. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
Julius U; Metzler W; Pietzsch J; Fassbender T; Klingel R
Int J Artif Organs; 2002 Dec; 25(12):1180-8. PubMed ID: 12518963
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced extracorporeal low-density lipoprotein precipitation.
Mellwig KP
Ther Apher Dial; 2003 Jun; 7(3):365-9. PubMed ID: 12924614
[TBL] [Abstract][Full Text] [Related]
5. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis.
Keller C
Ther Apher Dial; 2003 Jun; 7(3):345-9. PubMed ID: 12924611
[TBL] [Abstract][Full Text] [Related]
6. Extracorporal low-density lipoprotein elimination by immunoadsorption.
Ritter MM; Parhofer KG
Ther Apher Dial; 2003 Jun; 7(3):370-2. PubMed ID: 12924615
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein apheresis: an overview.
Bambauer R; Schiel R; Latza R
Ther Apher Dial; 2003 Aug; 7(4):382-90. PubMed ID: 12887719
[TBL] [Abstract][Full Text] [Related]
8. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia and LDL apheresis.
Morelli F; Carlier P; Giannini G; De Luigi MC; Dejana AM; Ruzzenenti MR
Int J Artif Organs; 2005 Oct; 28(10):1025-31. PubMed ID: 16288441
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
11. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
12. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
[TBL] [Abstract][Full Text] [Related]
13. [Kinetics of lipids and lipoproteins with determination of the recovery rate in the non-steady state following plasma, membrane filtration and dextran sulfate adsorption apheresis in hypercholesterolemia].
Schwartzkopff W; Gräfenhahn H; Nold A; von Baeyer H; Bimmermann A; Schleicher J
Biomed Tech (Berl); 1989 Oct; 34(10):232-42. PubMed ID: 2479419
[TBL] [Abstract][Full Text] [Related]
14. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia.
Koga N
Ther Apher; 2001 Aug; 5(4):244-51. PubMed ID: 11724508
[TBL] [Abstract][Full Text] [Related]
16. Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
Julius U; Parhofer KG; Heibges A; Kurz S; Klingel R; Geiss HC
J Clin Apher; 2007; 22(4):215-23. PubMed ID: 17455220
[TBL] [Abstract][Full Text] [Related]
17. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
[TBL] [Abstract][Full Text] [Related]
18. [Clinical long-term results of H.E.L.P.-apheresis].
Schuff-Werner P
Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
[TBL] [Abstract][Full Text] [Related]
19. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001.
Krebs A; Krebs K; Keller F
Int J Artif Organs; 2004 Feb; 27(2):137-48. PubMed ID: 15061475
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience.
Albayrak M; Yıldız A; Ateş N; Pala Ç
Transfus Apher Sci; 2019 Feb; 58(1):61-64. PubMed ID: 30545658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
